Purchase Order 75N94022P00281
Award Date 5/16/22
Potential Completion Date 3/31/27
Potential Value $200K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq laboratory tests to determine thyroid nodule malignancy for surgical decision making. The $72,000.00 award is part of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle between the VA and Cytopath Biopsy Lab Inc. to support cancer screening and diagnosis programs within the VA healthcare network. The contract...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq testing kits. The $320,000.00 contract is to deliver specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations to evaluate malignancy of thyroid nodules, to support screening programs at VA medical centers and associated healthcare networks...
- This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating as Cblpath, for $72,000.00. The contract is for the delivery of ThyroSeq laboratory tests to determine the malignancy of thyroid nodules in order to support surgical decisions. The contract is not set aside and has a period of performance through August 6, 2026. Cblpath is a for-profit organization specializing in anatomic pathology and molecular diagnostic...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for a base period of performance from May 1, 2016, to April 30, 2017, with a potential completion date of April 30, 2021. The contract has a ceiling value of $105,000.00 and is for the provision of specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations, to support cancer screening and diagnosis programs...
- This is a contract award to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Defense Health Agency for ThyroSeq genetic testing services. Cytopath Biopsy Lab is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next-generation genomic sequencing. The $148,142.40 firm fixed price contract is for the provision of ThyroSeq testing, which involves analyzing genetic mutations to evaluate the...
- This is a firm fixed price purchase order for $77,440.80 awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Cytopath Biopsy Lab Inc. (doing business as Cblpath) to provide laboratory testing services related to the ThyroSeq V.2 molecular diagnostic test. The award supports the agency's cancer screening and diagnosis programs, particularly for veterans and active military members. Cytopath Biopsy Lab Inc. has provided similar ThyroSeq testing services to...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide testing of thyroid nodules for cancer using non-surgical testing procedures. The $36,000.00 contract has a completion date of June 30, 2022 and was awarded on a non-competitive basis without a set-aside. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services,...
- The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...